UNICA IRIS Institutional Research Information System

MACCIONI, ELIAS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 303.618
NA - Nord America 10.910
AS - Asia 4.215
SA - Sud America 638
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 319.546
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 300.509
US - Stati Uniti d'America 10.748
CN - Cina 1.840
SG - Singapore 1.662
UA - Ucraina 947
SE - Svezia 765
BR - Brasile 528
DE - Germania 457
FI - Finlandia 273
GB - Regno Unito 263
VN - Vietnam 218
FR - Francia 107
IN - India 103
KR - Corea 97
CA - Canada 96
MA - Marocco 74
HK - Hong Kong 57
NL - Olanda 47
BD - Bangladesh 44
RU - Federazione Russa 43
AR - Argentina 41
MX - Messico 41
AT - Austria 40
PL - Polonia 35
PK - Pakistan 28
ZA - Sudafrica 27
TR - Turchia 23
BE - Belgio 22
ES - Italia 22
IE - Irlanda 21
IQ - Iraq 21
JP - Giappone 20
EC - Ecuador 19
ID - Indonesia 18
CO - Colombia 14
IR - Iran 14
KE - Kenya 14
CZ - Repubblica Ceca 13
LT - Lituania 11
TN - Tunisia 11
EG - Egitto 10
PY - Paraguay 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
VE - Venezuela 9
CR - Costa Rica 8
PA - Panama 8
PT - Portogallo 8
CL - Cile 7
EU - Europa 7
IL - Israele 7
NP - Nepal 7
RO - Romania 7
AE - Emirati Arabi Uniti 5
JO - Giordania 5
PE - Perù 5
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MU - Mauritius 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
KW - Kuwait 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
LB - Libano 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
GA - Gabon 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
Totale 319.542
Salva come PNG Salva come JPEG
Città #
Cagliari 294.570
Uta 5.289
Fairfield 990
Ashburn 878
Chandler 875
Woodbridge 848
Singapore 761
Dallas 653
Houston 645
Ann Arbor 531
Nyköping 529
Boardman 492
Jacksonville 492
Wilmington 411
Seattle 402
Beijing 391
Dearborn 378
Cambridge 303
New York 193
Los Angeles 181
Nanjing 169
Santa Clara 159
Shanghai 147
Boston 137
Hefei 132
Helsinki 124
The Dalles 115
Seoul 97
Buffalo 75
Ho Chi Minh City 71
Redwood City 64
Casablanca 63
Shenyang 58
Nanchang 54
Dong Ket 53
Munich 52
San Diego 51
Guangzhou 50
Hong Kong 48
Toronto 48
Milan 45
São Paulo 45
Hebei 41
Jiaxing 41
Verona 41
Changsha 40
Sassari 38
Amsterdam 34
Jinan 33
Warsaw 33
Hanoi 32
Tianjin 32
London 29
Mountain View 29
Redondo Beach 28
Kunming 27
Montreal 27
Frankfurt am Main 25
Vienna 25
Herndon 24
Norwalk 24
Phoenix 24
Chicago 23
Chennai 21
Brussels 20
Council Bluffs 20
Zhengzhou 20
Atlanta 19
Auburn Hills 18
Brooklyn 18
Hangzhou 18
Washington 18
Johannesburg 17
Orange 17
Pune 17
Taizhou 17
Tokyo 17
Dublin 16
Nuremberg 16
Ningbo 15
Rome 15
San Francisco 15
Wuhan 15
Columbus 13
Rio de Janeiro 13
Nairobi 12
Stockholm 12
Turku 12
Denver 11
Düsseldorf 11
Falls Church 11
Mumbai 11
Campinas 10
Mexico City 10
Orem 10
Brasília 9
Curitiba 9
Guarulhos 9
Jakarta 9
Manchester 9
Totale 312.849
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.694
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.030
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.679
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.657
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.632
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.486
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.409
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.402
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.353
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.336
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.293
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.277
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.148
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.912
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.902
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.741
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.733
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.711
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.556
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.508
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.436
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.397
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.379
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.369
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.338
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.281
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.267
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.264
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.228
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.178
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.163
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.063
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.044
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.005
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 2.994
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.988
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.935
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.882
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.870
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.820
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.738
MD protocol validation for the study of MAOB-inhibitor complexes 2.738
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.711
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.701
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.597
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.597
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.580
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.572
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.520
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.507
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.493
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.419
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.404
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.394
New promising scaffolds for the inhibition of monoamine oxidase B 2.271
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 2.258
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.230
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.137
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.100
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.086
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.073
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.046
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.039
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.039
null 1.949
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.930
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.900
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.898
New reactions of carbon suboxide with alkines 1.896
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.865
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.850
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.840
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.794
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.770
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.759
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.750
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.696
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.671
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.656
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.637
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.635
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.605
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.582
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.580
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.561
From classic to innovative approaches in HIV-1 infection treatment 1.524
null 1.499
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.435
null 1.415
null 1.406
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.383
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 1.299
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.259
9-fluorenones as new scaffolds for G-quadruplex DNA 1.198
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.153
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.143
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.131
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.090
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.083
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 1.083
Totale 270.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 377.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 377.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132.342 0 0 0 0 0 8.290 6.218 4.614 1.996 4.479 4.401 2.344
2021/202214.008 1.700 1.214 707 981 1.186 930 870 734 1.327 1.365 1.419 1.575
2022/202323.332 2.103 3.454 2.892 2.226 1.572 2.521 1.290 1.647 1.248 1.333 1.869 1.177
2023/202422.577 1.096 695 2.080 1.828 2.344 3.929 2.885 1.628 1.203 1.336 1.657 1.896
2024/202549.847 15.268 14.318 6.700 4.383 2.091 2.671 2.480 205 516 346 344 525
2025/20265.447 802 459 1.439 1.138 908 701 0 0 0 0 0 0
Totale 320.075